Defining relative androgen deficiency in aging men: how should testosterone be measured and what are the relationships between androgen levels and physical, sexual and emotional health?

被引:31
作者
Haren, MT
Morley, JE
Chapman, IM
O'Loughlin, PD
Wittert, GA
机构
[1] Univ Adelaide, Royal Adelaide Hosp, Dept Med, Adelaide, SA 5000, Australia
[2] St Louis Univ, Div Geriatr Med, St Louis, MO 63103 USA
[3] Vet Affairs Med Ctr, GRECC, St Louis, MO USA
[4] Inst Med & Vet Sci, Div Clin Biochem, Adelaide, SA 5000, Australia
关键词
testosterone; men; aging; muscle strength; body composition; cognitive function; libido;
D O I
10.1080/713605195
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
In men, bioavailable and free testosterone levels decline by about 1.0 and 1.2% per year, respectively, after the age of 40. The definition of clinically relevant androgen deficiency in the aging male remains uncertain. Clinical features common to both aging and androgen deficiency include decreased muscle mass and strength, and increased fatigue, increased fat mass, loss of libido, erectile dysfunction, impaired cognitive function and depression. It is, however, difficult to separate the effect on plasma testosterone of concomitant disease, compared with the effects of a decrease in testosterone levels alone. Testosterone supplementation has been shown to be effective in improving many of the clinical features of androgen deficiency in the older male, and is safe, at least in the short term. The maximum benefit occurs in those men with the lowest testosterone levels.
引用
收藏
页码:15 / 25
页数:11
相关论文
共 94 条
  • [1] Androgen-behavior correlations in hypogonadal men and eugonadal men - II. Cognitive abilities
    Alexander, GM
    Swerdloff, RS
    Wang, C
    Davidson, T
    McDonald, V
    Steiner, B
    Hines, M
    [J]. HORMONES AND BEHAVIOR, 1998, 33 (02) : 85 - 94
  • [2] THE EFFECTS OF EXOGENOUS TESTOSTERONE ON SEXUALITY AND MOOD OF NORMAL MEN
    ANDERSON, RA
    BANCROFT, J
    WU, FCW
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1992, 75 (06) : 1503 - 1507
  • [3] Long-term efficacy and safety of a permeation-enhanced testosterone transdermal system in hypogonadal men
    Arver, S
    Dobs, AS
    Meikle, AW
    Caramelli, KE
    Rajaram, L
    Sanders, SW
    Mazer, NA
    [J]. CLINICAL ENDOCRINOLOGY, 1997, 47 (06) : 727 - 737
  • [4] CHANGES IN PITUITARY-TESTICULAR SYSTEM WITH AGE
    BAKER, HWG
    BURGER, HG
    KRETSER, DMD
    HUDSON, B
    OCONNOR, S
    WANG, C
    MIROVICS, A
    COURT, J
    DUNLOP, M
    RENNIE, GC
    [J]. CLINICAL ENDOCRINOLOGY, 1976, 5 (04) : 349 - 372
  • [5] Endogenous sex hormones and cognitive function in older men
    Barrett-Connor, E
    Goodman-Gruen, D
    Patay, B
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (10) : 3681 - 3685
  • [6] Bioavailable testosterone and depressed mood in older men:: The Rancho Bernardo study
    Barrett-Connor, E
    Von Mühlen, DG
    Kritz-Silverstein, D
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (02) : 573 - 577
  • [7] ENDOGENOUS SEX-HORMONES AND CARDIOVASCULAR-DISEASE IN MEN - A PROSPECTIVE POPULATION-BASED STUDY
    BARRETTCONNOR, E
    KHAW, KT
    [J]. CIRCULATION, 1988, 78 (03) : 539 - 545
  • [8] Predictors of skeletal muscle mass in elderly men and women
    Baumgartner, RN
    Waters, DL
    Gallagher, D
    Morley, JE
    Garry, PJ
    [J]. MECHANISMS OF AGEING AND DEVELOPMENT, 1999, 107 (02) : 123 - 136
  • [9] BEHRE HM, 1994, CLIN ENDOCRINOL, V40, P341
  • [10] Testosterone replacement increases fat-free mass and muscle size in hypogonadal men
    Bhasin, S
    Storer, TW
    Berman, N
    Yarasheski, KE
    Clevenger, B
    Phillips, J
    Lee, WP
    Bunnell, TJ
    Casaburi, R
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (02) : 407 - 413